» Articles » PMID: 33002511

Azithromycin and Glucosamine May Amplify the Type 1 Interferon Response to RNA Viruses in a Complementary Fashion

Overview
Journal Immunol Lett
Date 2020 Oct 1
PMID 33002511
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Previous research demonstrates that, in clinically relevant concentrations, azithromycin can boost the ability of RNA viruses to induce type 1 interferon by amplifying the expression and virally-mediated activation of MDA5. O-GlcNAcylation of MAVS, a down-stream target of MDA5, renders it more effective for type 1 interferon induction. High-dose glucosamine administration up-regulates O-GlcNAcylation by increasing the cellular pool of UDP-N-acetylglucosamine. Hence, it is proposed that joint administration of azithromycin and high-dose glucosamine, early in the course of RNA virus infections, may interact in a complementary fashion to aid their control by enhancing type 1 interferon induction.

Citing Articles

A determination of pan-pathogen antimicrobials?.

Prathapan P Med Drug Discov. 2022; 14:100120.

PMID: 35098103 PMC: 8785259. DOI: 10.1016/j.medidd.2022.100120.


Molecular dynamics analysis of N-acetyl-D-glucosamine against specific SARS-CoV-2's pathogenicity factors.

Baysal O, Abdul Ghafoor N, Silme R, Ignatov A, Kniazeva V PLoS One. 2021; 16(5):e0252571.

PMID: 34043733 PMC: 8158907. DOI: 10.1371/journal.pone.0252571.


Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections.

DiNicolantonio J, McCarty M, Barroso-Aranda J Open Heart. 2021; 8(1).

PMID: 33741691 PMC: 7985934. DOI: 10.1136/openhrt-2020-001568.

References
1.
Setnikar I, Pacini M, Revel L . Antiarthritic effects of glucosamine sulfate studied in animal models. Arzneimittelforschung. 1991; 41(5):542-5. View

2.
Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N . In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest. 1995; 96(1):132-40. PMC: 185181. DOI: 10.1172/JCI118013. View

3.
Chuang K, Peng Y, Chien H, Lu M, Du H, Wu Y . Attenuation of LPS-induced lung inflammation by glucosamine in rats. Am J Respir Cell Mol Biol. 2013; 49(6):1110-9. DOI: 10.1165/rcmb.2013-0022OC. View

4.
Bell G, Kantor E, Lampe J, Shen D, White E . Use of glucosamine and chondroitin in relation to mortality. Eur J Epidemiol. 2012; 27(8):593-603. PMC: 3557824. DOI: 10.1007/s10654-012-9714-6. View

5.
Potempa L, Rajab I, Hart P, Bordon J, Fernandez-Botran R . Insights into the Use of C-Reactive Protein as a Diagnostic Index of Disease Severity in COVID-19 Infections. Am J Trop Med Hyg. 2020; 103(2):561-563. PMC: 7410479. DOI: 10.4269/ajtmh.20-0473. View